Literature DB >> 2962064

Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency.

M T Glover1, D J Atherton, R J Levinsky.   

Abstract

Five infants with a triad of symptoms comprising generalized erythroderma, failure to thrive, and diarrhea are presented. All of these children demonstrated significant immunologic abnormalities. This is a recognizable clinical syndrome that reflects immunodeficiency; however, the responsible immunodeficiencies do not appear to be the same in every case. Early investigation and appropriate therapy may considerably reduce morbidity, and mortality in children with this syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962064

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly.

Authors:  J G Ocejo-Vinyals; M J Lozano; P Sánchez-Velasco; J Escribano de Diego; J E Paz-Miguel; F Leyva-Cobián
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 2.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

3.  Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

Authors:  T Wada; K Takei; M Kudo; S Shimura; Y Kasahara; S Koizumi; K Kawa-Ha; Y Ishida; S Imashuku; H Seki; A Yachie
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 4.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Omenn syndrome with mutation in RAG1 gene.

Authors:  I Cherkaoui Jaouad; K Ouldim; S Ali Ou Alla; Y Kriouile; A Villa; A Sefiani
Journal:  Indian J Pediatr       Date:  2008-11-15       Impact factor: 1.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.